Page 81 - JSOM Fall 2020
P. 81

Previously published data on CWMP across all types of mil-  using pain assessments. As for the wound prophylaxis, we did
              itary units largely comprises survey studies. 26,27  Saur et al.   not have wound infection rates and are unable to compare
              reported 96% of 26 Role 1’s in Afghanistan surveyed from   outcomes related to the antimicrobial. Last, as a retrospective
              December 2013 to January 2014 did not supply their service   analysis we were unable to control for potential unmeasured
              members with CWMP.  Kotwal et al. revealed that CWMP   confounders and biases.  In addition, the trauma registry data
                                27
                                                                                   31
              distribution was limited to Special Operations Forces and   is subject to human errors in data entry, retrieval, and—perhaps
              conventional Marine units after interviewing all echelons of   most importantly—failure of inclusion. Previous studies have
              intratheater medical units in November 2012.  Neither study   demonstrated that US military prehospital documentation rates
                                                 26
              provided an explanation for the limited supply of CWMP. It   are poor, which limits data quality in the registry. 32,33
              is unclear why conventional military forces did not routinely
              issue CWMP; however, previous reports cite inadequate pre-  Conclusion
              deployment TCCC training and theater logistical supply issues
              as impediments to TCCC adherence. 4,19,26,27       Subjects receiving the CWMP were less severely injured com-
                                                                 pared to those who did not receive this intervention. The
              Two studies limited to these same special operations unit re-  CWMP had very infrequent use among those casualties with
              ported CWMP utilization for wound prophylaxis.  These re-  injury patterns meeting indications specified in the TCCC
                                                    5,6
              ports found 19%–21% of its subjects received the antibiotic   guidelines for use of this intervention.
              from the CWMP in the prehospital setting. We found only <1%
              of our subjects received CWMP agents, with 6 of 84 subjects   Acknowledgments
              included by way of moxifloxacin documentation only. Our   We would like to thank the Joint Trauma System Data Analy-
              significantly lower rate of CWMP utilization may be partially   sis Branch for their efforts with data acquisition.
              explained by the aforementioned differences in its distribution
              to special operations and conventional military forces. 26,27  The   Conflicts
              previously cited studies used a smaller population from the 75th   We have no conflicts to report.
              Ranger Regiment, which has had uniquely high TCCC adher-
              ence compared to the rest of the US Army.  Our dataset was   Funding
                                               5
              much larger, included causalities from conventional US military   We received no funding for this study.
              forces, and included service members from all branches of the
              US military. Taken together, these data suggest that the supply   Disclaimer
              limitations of CWMP during the study period likely explain in   Opinions or assertions contained herein are the private views
              large part our findings of infrequent use of this intervention.  of the authors and are not to be construed as official or as
                                                                 reflecting the views of the Department of the Air Force, the
              While it will be important to address this supply issue mov-  Department of the Army, Department of the Navy, or the De-
              ing  forward,  combatant  commands  should  consider  prefer-  partment of Defense.
              entially  issuing  CWMP  to  prehospital  healthcare  providers
              (e.g., medics) as opposed to every individual service member.   Ethics
              There are several reasons for this recommendation. First, our   The USAISR regulatory office reviewed protocol H-16-005
              data suggest that use of CWMP by nonmedical personnel may   and determined it was exempt from IRB oversight. We ob-
              be minimal. Second, pharmaceutical expiration, degradation   tained only deidentified data.
              in field conditions, and limited availability due to logistical
              constraints may complicate mass distribution and mainte-  Author Contributions
              nance. 4,6,19,26–28  Focusing on adequate supply and training for   SGS is the principal investigator and was involves in all aspect
              healthcare personnel will be likely to maximize their use, so   of this study  and accepts  overall responsibility. JFN, YMA,
              helping to prevent making perfect the enemy of the good. Last,   and JKM performed data interpretation, manuscript develop-
              there is a significant cost associated with universal issue of   ment, and manuscript revisions. MDA performed protocol de-
              these packs. CWMP currently cost $11.45 each, and over 2   velopment, data interpretation, manuscript development, and
              million US military Servicemembers deployed to Iraq and Af-  manuscript revisions.
              ghanistan by 2010. 29,30  Issuing every deploying service member
              a CWMP during this time period would therefore potentially   References
              have cost tens of millions of dollars.             1.  Belmont PJ, et al. Combat wounds in Iraq and Afghanistan from
                                                                   2005 to 2009. J Trauma Acute Care Surg. 2012;73(1):3–12.
              This study has several important limitations. First, our data are   2.  Holbrook TL, et al. Morphine use after combat injury in Iraq and
              limited to combat casualties admitted to military treatment fa-  post-traumatic stress disorder. N Engl J Med. 2010;362(2):110–117.
              cilities with surgical capabilities; therefore, patients discharged   3.  Gerhardt RT, et al. The effect of systemic antibiotic prophylaxis
              from or retained by Role 1 or traditional Role 2 treatment fa-  and wound irrigation on penetrating combat wounds in a return-
                                                                   to-duty population. Prehosp Emerg Care. 2009;13(4):500–504.
              cilities were not available for our analysis. Hence, our results   4.  Butler FK, et al. A triple-option analgesia plan for Tactical Combat
              are subject to selection bias. Second, the available data did not   Casualty Care: TCCC guidelines change 13-04. J Spec Oper Med.
              permit us to evaluate who administered the  CWMP. Conse-  2014;14(1):13–25.
              quently, we were unable to report the number of self, buddy, or   5.  Kotwal RS, et al. Eliminating preventable death on the battlefield.
              medical provider administrations among special operations and   Arch Surg. 2011;146(12):1350–1358.
              conventional military personnel. Third, pain scores before and   6.  Murray CK, et al. Efficacy of point-of-injury combat antimicrobi-
                                                                   als. J Trauma. 2011;71(2 Suppl 2):S307–S313.
              after analgesic administration were not available for our anal-  7.  Schauer SG, et al. Multicenter, prospective study of prehospital
              ysis. Therefore, we were not able to assess appropriate admin-  administration of analgesia in the U.S. Combat theater of Afghan-
              istration of CWMP analgesic agents and any perceived benefit   istan. Prehosp Emerg Care. 2017;21(6):744–749.

                                                                  Prehospital Combat Wound Medication Pack Administration  |  79
   76   77   78   79   80   81   82   83   84   85   86